GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 15 filers reported holding GAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,568 | -26.8% | 58,100 | 0.0% | 0.01% | -29.4% |
| Q2 2023 | $260,288 | -7.1% | 58,100 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $280,042 | +54.0% | 58,100 | 0.0% | 0.02% | +88.9% |
| Q4 2022 | $181,853 | -3.8% | 58,100 | 0.0% | 0.01% | +28.6% |
| Q3 2022 | $189,000 | -9.6% | 58,100 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $209,000 | -12.2% | 58,100 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $238,000 | -24.4% | 58,100 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $315,000 | -27.3% | 58,100 | 0.0% | 0.01% | -27.3% |
| Q3 2021 | $433,000 | -25.5% | 58,100 | 0.0% | 0.01% | -35.3% |
| Q2 2021 | $581,000 | -33.0% | 58,100 | 0.0% | 0.02% | -22.7% |
| Q1 2021 | $867,000 | – | 58,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|